Recent Advances in the Treatment of Prostate Cancer
Richard Lam, MD, Director of Clinical Research at Prostate Oncology Specialists, Inc.

Wednesday, November 18 2015 7 PM
CLU - Swenson 101

Prostate cancer covers a large spectrum of conditions from latent to life-threatening. The array of treatments encompasses many options including active surveillance, hormone therapy, immunotherapy, surgery, radiation, brachytherapy, cryotherapy, focal therapy, proton therapy, nutritional and alternative therapies, HIFU and chemotherapy. The choice needs to be based judiciously on the unique profile of each individual. And with prostate cancer, the patient and the doctor need to weigh in the treatment’s impact on the individual’s quality-of-life. Learning about the various treatments is empowering and leads a solution that is personalized and that balances the management of the condition and quality of life.

Richard Lam, MD, Prostate Oncology Specialists, Inc.

Richard Lam, MD, is a board-certified internist and oncologist who has been specializing full time in the treatment of prostate cancer since 2001. He is director of clinical research at Prostate Oncology Specialists, Inc. Dr. Lam has written numerous articles based on his research. He is an active member of the American Society of Clinical Oncology and the American Society of Hematology. Dr. Lam continues to promote prostate cancer awareness and education by giving lectures at various medical conferences and prostate support groups throughout the country. He is particularly interested in utilizing state-of-the-art therapeutics for advanced prostate cancer.
Dr. Lam received his undergraduate degree in biology, magna cum laude, at UCLA. He then went on to earn his medical degree at UCLA School of Medicine before completing his residency training in the specialty of internal medicine at UCLA Center of Health Sciences. He completed his oncology and hematology fellowship at Harbor-UCLA Medical Center.